Batista, R.; Lima, L.; Vinagre, J.; Pinto, V.; Lyra, J.; Máximo, V.; Santos, L.; Soares, P.
TERT Promoter Mutation as a Potential Predictive Biomarker in BCG-Treated Bladder Cancer Patients. Int. J. Mol. Sci. 2020, 21, 947.
https://doi.org/10.3390/ijms21030947
AMA Style
Batista R, Lima L, Vinagre J, Pinto V, Lyra J, Máximo V, Santos L, Soares P.
TERT Promoter Mutation as a Potential Predictive Biomarker in BCG-Treated Bladder Cancer Patients. International Journal of Molecular Sciences. 2020; 21(3):947.
https://doi.org/10.3390/ijms21030947
Chicago/Turabian Style
Batista, Rui, Luís Lima, João Vinagre, Vasco Pinto, Joana Lyra, Valdemar Máximo, Lúcio Santos, and Paula Soares.
2020. "TERT Promoter Mutation as a Potential Predictive Biomarker in BCG-Treated Bladder Cancer Patients" International Journal of Molecular Sciences 21, no. 3: 947.
https://doi.org/10.3390/ijms21030947
APA Style
Batista, R., Lima, L., Vinagre, J., Pinto, V., Lyra, J., Máximo, V., Santos, L., & Soares, P.
(2020). TERT Promoter Mutation as a Potential Predictive Biomarker in BCG-Treated Bladder Cancer Patients. International Journal of Molecular Sciences, 21(3), 947.
https://doi.org/10.3390/ijms21030947